Zobrazeno 1 - 10
of 343
pro vyhledávání: '"M, Blumenfeld"'
Autor:
Andrew M. Blumenfeld, Richard B. Lipton, Stephen Silberstein, Stewart J. Tepper, Larry Charleston, Stephen Landy, Deena E. Kuruvilla, Aubrey Manack Adams
Publikováno v:
Neurology and Therapy, Vol 12, Iss 5, Pp 1533-1551 (2023)
Abstract Migraine is a neurologic disease with a complex pathophysiology that can be controlled with current treatment options but not cured. Therefore, treatment expectations are highly variable. The concept of migraine freedom was recently introduc
Externí odkaz:
https://doaj.org/article/bb3f6e1700ef433e92ce463429385b39
Autor:
Andrew M. Blumenfeld, James P. Boyd
Publikováno v:
BMC Neurology, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Objective To assess the nocioceptive input of habitual nocturnal jaw clenching that acts as a contributing factor in migraine pathogenesis. Background Habitual nocturnal jaw clenching has been implicated as a trigger, particularly in those w
Externí odkaz:
https://doaj.org/article/af287a66c88145f48bd811231cd2fdd6
Autor:
David B. Clemow, Kirk W. Johnson, Helen M. Hochstetler, Michael H. Ossipov, Ann M. Hake, Andrew M. Blumenfeld
Publikováno v:
The Journal of Headache and Pain, Vol 21, Iss 1, Pp 1-13 (2020)
Abstract Migraine is a leading cause of disability worldwide, but it is still underdiagnosed and undertreated. Research on the pathophysiology of this neurological disease led to the discovery that calcitonin gene-related peptide (CGRP) is a key neur
Externí odkaz:
https://doaj.org/article/2862c682cbcd488db55c7f0c23bb485b
Autor:
William B. Young, J. Ivan Lopez, John F. Rothrock, Amelia Orejudos, Aubrey Manack Adams, Richard B. Lipton, Andrew M. Blumenfeld
Publikováno v:
The Journal of Headache and Pain, Vol 20, Iss 1, Pp 1-10 (2019)
Abstract Background OnabotulinumtoxinA is effective in preventing chronic migraine (CM); however, the benefit of onabotulinumtoxinA in patients with CM with daily headache is unknown because these patients are typically excluded from clinical trials.
Externí odkaz:
https://doaj.org/article/fe8740504e1e4f8da398ab5cc3ea9155
Autor:
William B. Young, J. Ivan Lopez, John F. Rothrock, Amelia Orejudos, Aubrey Manack Adams, Richard B. Lipton, Andrew M. Blumenfeld
Publikováno v:
The Journal of Headache and Pain, Vol 20, Iss 1, Pp 1-10 (2019)
Abstract Background OnabotulinumtoxinA is effective in treating chronic migraine (CM), but there are limited data assessing how allodynia affects preventive treatment responses. This subanalysis of the 108-week, multicenter, open-label COMPEL Study a
Externí odkaz:
https://doaj.org/article/34919c94b35746dba55267f019599f2b
Autor:
Stewart J. Tepper, Liron Rabany, Robert P. Cowan, Timothy R. Smith, Brian M. Grosberg, Bradley D. Torphy, Dagan Harris, Maya Vizel, Alon Ironi, Alit Stark‐Inbar, Andrew M. Blumenfeld
Publikováno v:
Headache: The Journal of Head and Face Pain. 63:377-389
Autor:
Andrew M, Blumenfeld, Ramesh, Boinpally, Rosa, De Abreu Ferreira, Joel M, Trugman, Brett, Dabruzzo, Jessica, Ailani, Richard B, Lipton
Publikováno v:
Headache: The Journal of Head and Face Pain. 63:322-332
To evaluate potential drug-drug interactions of ubrogepant and atogepant.Ubrogepant and atogepant, calcitonin gene-related peptide (CGRP) receptor antagonists, are recently approved drugs for acute and preventive treatment of migraine, respectively.
Autor:
Messoud Ashina, Stewart J. Tepper, Uwe Reuter, Andrew M. Blumenfeld, Susan Hutchinson, Jing Xia, Rosa Miceli, Lawrence Severt, Michelle Finnegan, Joel M. Trugman
Publikováno v:
Headache: The Journal of Head and Face Pain. 63:79-88
Autor:
Andrew M. Blumenfeld, Gavneet Kaur, Anadi Mahajan, Hemlata Shukla, Katherine Sommer, Amy Tung, Kerry L. Knievel
Publikováno v:
Pain and Therapy. 12:251-274
Numerous medications are used for the preventive treatment of chronic migraine (CM), including oral treatments, onabotulinumtoxinA (onabotA; BOTOX), and calcitonin gene-related peptide (CGRP) monoclonal antibodies (mAbs). Despite substantial clinical
Autor:
Andrew M. Blumenfeld, Atul T. Patel, Ira M. Turner, Kathleen B. Mullin, Aubrey Manack Adams, John F. Rothrock
Publikováno v:
Journal of Primary Care & Community Health, Vol 11 (2020)
Introduction/Objective: Chronic migraine (CM) is associated with impaired health-related quality of life and substantial socioeconomic burden, but many people with CM are underdiagnosed and do not receive appropriate preventive treatment. Onabotulinu
Externí odkaz:
https://doaj.org/article/b03d6ce85948495295e184bae23bfbf3